Literature DB >> 3874261

Induction of influenza A virus cross-reactive cytotoxic T cells by a nucleoprotein/haemagglutinin preparation.

D C Wraith, B A Askonas.   

Abstract

An ammonium deoxycholate fraction from bromelain-treated influenza A virus was highly enriched for virus nucleoprotein and contained residual haemagglutinin (NP/HA). The preparation did not contain detectable levels of matrix or neuraminidase proteins and was free of infectious virus. NP/HA effectively primed mice for cytotoxic T cells which lysed syngeneic cells infected with any type A influenza virus. Furthermore, NP/HA generated A-type virus cross-reactive cytotoxic T cells when added in vitro to spleen cells from mice previously primed with infectious influenza A virus. These properties imply that NP/HA has potential as a vaccine for heterotypic influenza A immunity.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3874261     DOI: 10.1099/0022-1317-66-6-1327

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  23 in total

1.  Immune-stimulating complexes containing Quil A and protein antigen prime class I MHC-restricted T lymphocytes in vivo and are immunogenic by the oral route.

Authors:  A M Mowat; A M Donachie; G Reid; O Jarrett
Journal:  Immunology       Date:  1991-03       Impact factor: 7.397

2.  Induction of single and dual cytotoxic T-lymphocyte responses to viral proteins in mice using recombinant hybrid Ty-virus-like particles.

Authors:  G T Layton; S J Harris; J Myhan; D West; F Gotch; M Hill-Perkins; J S Cole; N Meyers; S Woodrow; T J French; S E Adams; A J Kingsman
Journal:  Immunology       Date:  1996-02       Impact factor: 7.397

Review 3.  New aspects of vaccine development.

Authors:  F Y Liew
Journal:  Clin Exp Immunol       Date:  1985-11       Impact factor: 4.330

4.  Influenza nucleoprotein-specific cytotoxic T-cell clones are protective in vivo.

Authors:  P M Taylor; B A Askonas
Journal:  Immunology       Date:  1986-07       Impact factor: 7.397

5.  Influenza virus-specific cytotoxic T-cell recognition: stimulation of nucleoprotein-specific clones with intact antigen.

Authors:  D C Wraith; A E Vessey
Journal:  Immunology       Date:  1986-10       Impact factor: 7.397

Review 6.  Recognition of influenza virus proteins by cytotoxic T lymphocytes.

Authors:  A R Townsend
Journal:  Immunol Res       Date:  1987       Impact factor: 2.829

7.  CD4-positive and CD8-positive cytotoxic T lymphocytes contribute to human papillomavirus type 16 E6 and E7 responses.

Authors:  M Nakagawa; D P Stites; J M Palefsky; Z Kneass; A B Moscicki
Journal:  Clin Diagn Lab Immunol       Date:  1999-07

8.  Low responder MHC alleles for Tc recognition of influenza nucleoprotein.

Authors:  P Pala; B A Askonas
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

9.  Influenza vaccination in older patients. Immunogenicity, epidemiology and available agents.

Authors:  H Glathe; W Lange
Journal:  Drugs Aging       Date:  1995-05       Impact factor: 3.923

Review 10.  Development of a universal CTL-based vaccine for influenza.

Authors:  Diego Esteban Cargnelutti; María Victoria Sánchez; Nora Marta Mattion; Eduardo Alberto Scodeller
Journal:  Bioengineered       Date:  2013-01-21       Impact factor: 3.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.